Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Total Liabilities (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Total Liabilities for 5 consecutive years, with $44.6 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 16.71% to $44.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.6 million through Dec 2025, down 16.71% year-over-year, with the annual reading at $44.6 million for FY2025, 16.71% down from the prior year.
  • Total Liabilities for Q4 2025 was $44.6 million at Werewolf Therapeutics, down from $50.0 million in the prior quarter.
  • The five-year high for Total Liabilities was $74.0 million in Q1 2023, with the low at $7.1 million in Q1 2021.
  • Average Total Liabilities over 5 years is $44.0 million, with a median of $49.8 million recorded in 2024.
  • The sharpest move saw Total Liabilities skyrocketed 413.29% in 2022, then dropped 25.44% in 2024.
  • Over 5 years, Total Liabilities stood at $26.5 million in 2021, then soared by 43.25% to $37.9 million in 2022, then soared by 67.4% to $63.5 million in 2023, then dropped by 15.63% to $53.5 million in 2024, then decreased by 16.71% to $44.6 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $44.6 million, $50.0 million, and $51.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.